扩散加权成像鉴别兔炎性及转移性淋巴结肿大的实验研究

Objective To investigate the value of MR DWI in comparing inflammatory with metastastic lymph node in animal models of lymph disease.Methods Eighteen rabbits with benign lymphadenopathy and 9 rabbits with malignant lymphadenopathy underwent routine MRI and DWI examination.Independent-samples t test was used to compare the sizes and apparent diffusion coefficient (ADC) values between the two groups.Results Thirty-four inflammatory lymph nodes and 18 metastastic lymph nodes were observed .The size of lymph nodes was (8.14±2.79) and (6.29±1.48) mm in the benign and malignant groups, respectively.There was no significant statistical difference between the sizes of the two groups (t=2.624, P 0.05).Mean ADC value of lymph nodes was (1.19±0.31)×10-3mm2/s and (1.31±0.27)×10-3mm2/s in the benign and malignant groups, respectively.There was no significant statistical difference between the ADC values of benign and malignant lymph nodes (t=1.449,P 0.05).Conclusion DWI sequence can be used to show lymphadenopathy, but the ADC value is insufficient to differentiate benign lymph nodes from malignant lymphadenopathy.     

扩散加权成像鉴别兔炎性及转移性淋巴结肿大的实验研究

Objective To investigate the value of MR DWI in comparing inflammatory with metastastic lymph node in animal models of lymph disease.Methods Eighteen rabbits with benign lymphadenopathy and 9 rabbits with malignant lymphadenopathy underwent routine MRI and DWI examination.Independent-samples t test was used to compare the sizes and apparent diffusion coefficient (ADC) values between the two groups.Results Thirty-four inflammatory lymph nodes and 18 metastastic lymph nodes were observed .The size of lymph nodes was (8.14±2.79) and (6.29±1.48) mm in the benign and malignant groups, respectively.There was no significant statistical difference between the sizes of the two groups (t=2.624, P 0.05).Mean ADC value of lymph nodes was (1.19±0.31)×10-3mm2/s and (1.31±0.27)×10-3mm2/s in the benign and malignant groups, respectively.There was no significant statistical difference between the ADC values of benign and malignant lymph nodes (t=1.449,P 0.05).Conclusion DWI sequence can be used to show lymphadenopathy, but the ADC value is insufficient to differentiate benign lymph nodes from malignant lymphadenopathy.     

扩散加权成像鉴别兔炎性及转移性淋巴结肿大的实验研究

Objective To investigate the value of MR DWI in comparing inflammatory with metastastic lymph node in animal models of lymph disease.Methods Eighteen rabbits with benign lymphadenopathy and 9 rabbits with malignant lymphadenopathy underwent routine MRI and DWI examination.Independent-samples t test was used to compare the sizes and apparent diffusion coefficient (ADC) values between the two groups.Results Thirty-four inflammatory lymph nodes and 18 metastastic lymph nodes were observed .The size of lymph nodes was (8.14±2.79) and (6.29±1.48) mm in the benign and malignant groups, respectively.There was no significant statistical difference between the sizes of the two groups (t=2.624, P 0.05).Mean ADC value of lymph nodes was (1.19±0.31)×10-3mm2/s and (1.31±0.27)×10-3mm2/s in the benign and malignant groups, respectively.There was no significant statistical difference between the ADC values of benign and malignant lymph nodes (t=1.449,P 0.05).Conclusion DWI sequence can be used to show lymphadenopathy, but the ADC value is insufficient to differentiate benign lymph nodes from malignant lymphadenopathy.     

扩散加权成像鉴别兔炎性及转移性淋巴结肿大的实验研究

Objective To investigate the value of MR DWI in comparing inflammatory with metastastic lymph node in animal models of lymph disease.Methods Eighteen rabbits with benign lymphadenopathy and 9 rabbits with malignant lymphadenopathy underwent routine MRI and DWI examination.Independent-samples t test was used to compare the sizes and apparent diffusion coefficient (ADC) values between the two groups.Results Thirty-four inflammatory lymph nodes and 18 metastastic lymph nodes were observed .The size of lymph nodes was (8.14±2.79) and (6.29±1.48) mm in the benign and malignant groups, respectively.There was no significant statistical difference between the sizes of the two groups (t=2.624, P 0.05).Mean ADC value of lymph nodes was (1.19±0.31)×10-3mm2/s and (1.31±0.27)×10-3mm2/s in the benign and malignant groups, respectively.There was no significant statistical difference between the ADC values of benign and malignant lymph nodes (t=1.449,P 0.05).Conclusion DWI sequence can be used to show lymphadenopathy, but the ADC value is insufficient to differentiate benign lymph nodes from malignant lymphadenopathy.     

扩散加权成像鉴别兔炎性及转移性淋巴结肿大的实验研究

Objective To investigate the value of MR DWI in comparing inflammatory with metastastic lymph node in animal models of lymph disease.Methods Eighteen rabbits with benign lymphadenopathy and 9 rabbits with malignant lymphadenopathy underwent routine MRI and DWI examination.Independent-samples t test was used to compare the sizes and apparent diffusion coefficient (ADC) values between the two groups.Results Thirty-four inflammatory lymph nodes and 18 metastastic lymph nodes were observed .The size of lymph nodes was (8.14±2.79) and (6.29±1.48) mm in the benign and malignant groups, respectively.There was no significant statistical difference between the sizes of the two groups (t=2.624, P 0.05).Mean ADC value of lymph nodes was (1.19±0.31)×10-3mm2/s and (1.31±0.27)×10-3mm2/s in the benign and malignant groups, respectively.There was no significant statistical difference between the ADC values of benign and malignant lymph nodes (t=1.449,P 0.05).Conclusion DWI sequence can be used to show lymphadenopathy, but the ADC value is insufficient to differentiate benign lymph nodes from malignant lymphadenopathy.     

扩散加权成像鉴别兔炎性及转移性淋巴结肿大的实验研究

Objective To investigate the value of MR DWI in comparing inflammatory with metastastic lymph node in animal models of lymph disease.Methods Eighteen rabbits with benign lymphadenopathy and 9 rabbits with malignant lymphadenopathy underwent routine MRI and DWI examination.Independent-samples t test was used to compare the sizes and apparent diffusion coefficient (ADC) values between the two groups.Results Thirty-four inflammatory lymph nodes and 18 metastastic lymph nodes were observed .The size of lymph nodes was (8.14±2.79) and (6.29±1.48) mm in the benign and malignant groups, respectively.There was no significant statistical difference between the sizes of the two groups (t=2.624, P 0.05).Mean ADC value of lymph nodes was (1.19±0.31)×10-3mm2/s and (1.31±0.27)×10-3mm2/s in the benign and malignant groups, respectively.There was no significant statistical difference between the ADC values of benign and malignant lymph nodes (t=1.449,P 0.05).Conclusion DWI sequence can be used to show lymphadenopathy, but the ADC value is insufficient to differentiate benign lymph nodes from malignant lymphadenopathy.     

扩散加权成像鉴别兔炎性及转移性淋巴结肿大的实验研究

Objective To investigate the value of MR DWI in comparing inflammatory with metastastic lymph node in animal models of lymph disease.Methods Eighteen rabbits with benign lymphadenopathy and 9 rabbits with malignant lymphadenopathy underwent routine MRI and DWI examination.Independent-samples t test was used to compare the sizes and apparent diffusion coefficient (ADC) values between the two groups.Results Thirty-four inflammatory lymph nodes and 18 metastastic lymph nodes were observed .The size of lymph nodes was (8.14±2.79) and (6.29±1.48) mm in the benign and malignant groups, respectively.There was no significant statistical difference between the sizes of the two groups (t=2.624, P 0.05).Mean ADC value of lymph nodes was (1.19±0.31)×10-3mm2/s and (1.31±0.27)×10-3mm2/s in the benign and malignant groups, respectively.There was no significant statistical difference between the ADC values of benign and malignant lymph nodes (t=1.449,P 0.05).Conclusion DWI sequence can be used to show lymphadenopathy, but the ADC value is insufficient to differentiate benign lymph nodes from malignant lymphadenopathy.     

扩散加权成像鉴别兔炎性及转移性淋巴结肿大的实验研究

Objective To investigate the value of MR DWI in comparing inflammatory with metastastic lymph node in animal models of lymph disease.Methods Eighteen rabbits with benign lymphadenopathy and 9 rabbits with malignant lymphadenopathy underwent routine MRI and DWI examination.Independent-samples t test was used to compare the sizes and apparent diffusion coefficient (ADC) values between the two groups.Results Thirty-four inflammatory lymph nodes and 18 metastastic lymph nodes were observed .The size of lymph nodes was (8.14±2.79) and (6.29±1.48) mm in the benign and malignant groups, respectively.There was no significant statistical difference between the sizes of the two groups (t=2.624, P 0.05).Mean ADC value of lymph nodes was (1.19±0.31)×10-3mm2/s and (1.31±0.27)×10-3mm2/s in the benign and malignant groups, respectively.There was no significant statistical difference between the ADC values of benign and malignant lymph nodes (t=1.449,P 0.05).Conclusion DWI sequence can be used to show lymphadenopathy, but the ADC value is insufficient to differentiate benign lymph nodes from malignant lymphadenopathy.     

扩散加权成像鉴别兔炎性及转移性淋巴结肿大的实验研究

Objective To investigate the value of MR DWI in comparing inflammatory with metastastic lymph node in animal models of lymph disease.Methods Eighteen rabbits with benign lymphadenopathy and 9 rabbits with malignant lymphadenopathy underwent routine MRI and DWI examination.Independent-samples t test was used to compare the sizes and apparent diffusion coefficient (ADC) values between the two groups.Results Thirty-four inflammatory lymph nodes and 18 metastastic lymph nodes were observed .The size of lymph nodes was (8.14±2.79) and (6.29±1.48) mm in the benign and malignant groups, respectively.There was no significant statistical difference between the sizes of the two groups (t=2.624, P 0.05).Mean ADC value of lymph nodes was (1.19±0.31)×10-3mm2/s and (1.31±0.27)×10-3mm2/s in the benign and malignant groups, respectively.There was no significant statistical difference between the ADC values of benign and malignant lymph nodes (t=1.449,P 0.05).Conclusion DWI sequence can be used to show lymphadenopathy, but the ADC value is insufficient to differentiate benign lymph nodes from malignant lymphadenopathy.     

含软骨基质型肉瘤的MR钆喷替酸葡甲胺增强和扩散加权成像特点

Objective To study the Gadolinium-enhanced MRI and diffusion weighted imaging (DWI) characteristics of the chondroid matrix-forming sarcomas.Methods Contrast-enhanced MRI and DWI were performed in 14 eases of chondroid matrix-forming sarcomas (10 chondrosarcomas,4 chondroblastic esteosarcomas) and 13 cases of other types of osteosarcomas.DWI was obtained with a single-shot echo-planar imaging (EPI) sequence using a 1.5 T MR imager with two different b values of 0 and 700 s/mm2.The apparent diffusion coefficient (ADC) values were obtained in GE Functiontool software.The contrast-enhancement pattern was evaluated and the ADC values of ehondroid matrix-forming sarcomas was compared with that of other types of asteosarcoma.Independent sample t-test was performed to evaluate the difference of ADC values between the group of chondroid matrix-forming sarcoma and the group of other types of osteosarcoma.In addition, nonparametrie test was used to assess the difference of ADC values between the chondrosareoma and the chondroblastic osteosarcoma.P value less than 0.05 was considered to represent a statistical significance.Results For 14 eases of ehondroid matrix-forming sarcomas, peripheral enhancement was found in all cases, septonodular enhancement was identified in 12 cases.While 13 eases of other types of osteosarcowas demonstrated heterogeneous enhancement.The mean ADC value of chondroid matrix-forming sarcomas [(2.56 ±0.35) × 10 -3 mm2/s] was significantly higher than that of other types of osteosarcoma [( 1.16±0.20) × 10-3 mm2/s] (t = 12.704,P <0.O1 ).There was no significant difference in the ADC value between the chondrosarcoma and the chondroblastie osteesarcama(Z =0.507 ,P =0.959).Conclusion Contrast-enhanced MRI and DWI can improve differentiation between chondroid matrix-forming sarcomas and other types of osteosarcomas.     

模拟高原缺氧不同时间对大鼠心肌线粒体功能的影响及其在习服—适应中的意义

目的：观察模拟高原缺氧不同时间对心肌线粒体的影响,探讨模拟高原缺氧对机体影响的细胞机制以及线粒体功能改变在机体对缺氧习服—适应中的意义,为高原缺氧性疾病的防治提供理论基础。方法：观察急性连续缺氧（模拟５ ０００ｍ 高原）３、１２、３６ 和７２ 小时以及慢性间断缺氧１４、２８ 和４２天对大鼠心肌线粒体的影响。测定了线粒体呼吸控制率、琥珀酸脱氢酶及细胞色素氧化酶活性和线粒体丙二醛含量。结果：各时间点的线粒体呼吸控制率比对照组都显著降低,急性缺氧的下降程度较慢性组为甚,其中急性缺氧３ 小时组抑制程度最显著。细胞色素氧化酶活性在急性缺氧３ 小时末显著降低,随后有所回升,而慢性缺氧则使细胞色素氧化酶活性升高。琥珀酸脱氢酶活性在急性缺氧组升高。线粒体丙二醛含量在急性与慢性缺氧各时间点均显著升高,其中以３ 小时组的丙二醛值为最高。结论：急性缺氧、尤其是在最初３ 小时心肌线粒体呼吸功能受抑制较严重,线粒体细胞色素氧化酶和琥珀酸脱氢酶活性升高可能有一定的代偿适应意义。     

Imaging of the larynx and hypopharynx

The purpose of this article is to review currently used imaging protocols for the evaluation of pathologic conditions of the larynx and hypopharynx, to describe key anatomic structures in the larynx and hypopharynx that are relevant to tumor spread and to discuss the clinical role of Computed Tomography (CT), Magnetic Resonance Imaging (MRI) and PET CT in the pretherapeutic workup and posttherapeutic follow-up of patients with squamous cell carcinoma of this region. A detailed discussion of the characteristic neoplastic submucosal invasion patterns, including extension to the preepiglottic space, paraglottic space and laryngeal cartilages and the implications of imaging for tumor staging and treatment planning is provided. The present article also reviews less common tumors of this region, such as chondrosarcoma, lymphoma, minor salivary gland tumors and lipoma. As the majority of non-neoplastic conditions do not require imaging the role of CT and MRI is discussed in some particular situations, such as to delineate cysts and laryngoceles, abscess formation in inflammatory conditions, to evaluate laryngeal and hypopharyngeal involvement in granulomatous and autoimmune diseases, and to evaluate the extent of laryngeal fractures due to severe blunt trauma.     

高原地区肝功能异常者红细胞免疫功能的观察

目的：观察则察地区２７例和甘德地区３０例肝功能异常的患者红细胞免疫功能测定；方法：采用红细胞Ｃ３ｂ受体花环率和复合花环经试验；结果：两个地区肝功能异常患者的红细胞Ｃ３ｂ受体花环率均低于正常人对照组，而红细胞免疫复合物花环经高于正常人对照组；结论：在高原地区肝功能异常患者在治疗的同时，应纠正和改善红细胞免疫调节功能。     

Endovascular Venous Thrombolysis in Children Younger than 24 Months

PurposeTo evaluate the technical feasibility and safety of percutaneous endovascular thrombolysis for extremity deep venous thrombosis (DVT) in children < 24 months old.Materials and MethodsA retrospective chart review of a clinical and imaging database was performed for pediatric patients who underwent endovascular therapy for DVT between January 2010 and July 2013. Indications, techniques, technical and clinical success, and complications were reviewed. Techniques for thrombolysis included catheter-directed therapy (CDT) using alteplase infusion via a multi–side hole catheter, mechanical thrombectomy, and angioplasty. Short-term outcomes were assessed using surgical and imaging follow-up examinations for patency of the targeted vessel. Patients included 11 children (mean age, 9 mo; range, 3 wk–23 mo) who consecutively underwent endovascular thrombolysis for upper extremity (n = 6) or lower extremity (n = 5) DVT. The most common indication was preservation of venous access for future cardiac surgery or medical therapy.ResultsThe most common risk factor was the presence of a central venous catheter (10 of 11 patients). All patients with upper extremity DVT had congenital heart disease. CDT and angioplasty were performed in all patients. Venous patency was established in all patients. A grade III (95%–100%) thrombolysis response was achieved in seven patients, and a grade II (50%–95%) thrombolysis response was achieved in four patients. A major complication of pulmonary embolism occurred in one patient with upper extremity thrombolysis and was managed by intravenous systemic alteplase and heparin. No recurrence of thrombosis was found on average follow-up of 11.8 months (range, 1–41 mo).ConclusionsPercutaneous endovascular thrombolysis for extremity DVT is safe and technically feasible in children < 24 months old.     

Closure of the Axillary Artery Puncture Site with StarClose System after Endovascular Interventions

The use of the StarClose vascular closure device for puncture site hemostasis after therapeutic endovascular interventions performed through the axillary artery under anticoagulant therapy in six patients is reported. Three minor complications, including hematoma, prolonged hemostasis, and pain, occurred in three patients. Based on this limited experience, this method can be used safely for axillary artery puncture site hemostasis after endovascular procedures without significant complications.     

Endovascular Recanalization of Native Chronic Total Occlusions in Patients with Failed Lower-Extremity Bypass Grafts

PurposeTo investigate the feasibility, safety, and outcome of endovascular recanalization of native chronic total occlusions (CTOs) in patients with failed lower-extremity bypass grafts.Materials and MethodsRetrospective review of 19 limbs in 18 patients with failed lower-extremity bypass grafts that underwent recanalization of native arterial occlusions between February 2009 and April 2013 was performed. Nine of the limbs presented with acute ischemia and 10 presented with chronic ischemia, including eight with critical limb ischemia and two with disabling claudication.ResultsThe mean patency of the failed bypass grafts (63% venous) was 27 months. All limbs had Transatlantic Inter-Society Consensus class D lesions involving the native circulation. Technical success of the endovascular recanalization procedure was achieved in all but one limb (95%). The mean ankle brachial indices before and after treatment were 0.34 and 0.73, respectively. There were no major complications or emergency amputations. Mean patient follow-up was 64 weeks, and two patients were lost to follow-up. Primary patency rates at 3, 6, and 12 months were 87%, 48%, and 16%, respectively. Successful secondary procedures were performed in seven patients, with secondary patency rates at 3, 6, and 12 months of 88%, 73%, and 44%, respectively. Limb salvage rates at 12 and 24 months were 94% and 65%, and amputation-free survival rates at 12 and 24 months were 87% and 60%, respectively.ConclusionsEndovascular recanalization of native CTOs in patients with failed lower-extremity bypass grafts is technically feasible and safe and results in acceptable limb salvage.     

Revascularization for Critical Limb Ischemia Using the SpiderFX Embolic Protection Device in the Below-the-Knee Circulation: Initial Results

PurposeTo examine the safety and efficacy of the SpiderFX embolic protection device (EPD) in the below-the-knee (BTK) circulation in patients with critical limb ischemia (CLI).Materials and MethodsA single-center retrospective review was performed to identify patients with CLI and single-vessel runoff in whom the SpiderFX EPD was used in the BTK circulation. Technical success and device-related complications were the primary endpoints. Retrieval of macroscopic debris in the EPD, 1-year freedom from major adverse limb events (MALEs), and 30-day perioperative death were also evaluated. A major amputation, surgical bypass, endovascular thrombectomy, or endovascular thrombolysis was considered a MALE. Thirty-six patients (21 men; mean age, 75.8 y) treated between 2008 and 2013 had endovascular revascularization with use of the SpiderFX EPD in the BTK circulation.ResultsThe SpiderFX EPD was successfully deployed in all cases; the technical success rate of revascularization was 100%. Two minor and zero major complications were observed related to the SpiderFX. Two MALEs, a major amputation and a subsequent surgical bypass, were observed in the cohort. All MALEs occurred within 1 year of treatment (1-y freedom from MALE rate, 90%). Debris was retrieved in the SpiderFX device in 47% of patients.ConclusionsThe use of the SpiderFX EPD in the BTK circulation in patients with CLI is safe and frequently retrieves debris.     

Apparent Diffusion Coefficient of Uterine Leiomyoma as a Predictor of the Potential Response to Uterine Artery Embolization

PurposeTo determine the utility of the apparent diffusion coefficient (ADC) of uterine leiomyoma for prediction of the potential response to uterine artery embolization (UAE).Materials and MethodsThis prospective study included 49 patients with uterine leiomyomas who underwent diffusion-weighted magnetic resonance (MR) imaging before UAE between May 2011 and January 2012. All patients also underwent 3-month follow-up MR imaging after UAE. Using conventional and diffusion-weighted MR imaging sequences, 72 uterine leiomyomas ≥ 3 cm were prospectively evaluated. The volume of each leiomyoma was calculated, and quantitative measurement of ADC was performed. Regression analysis was used to evaluate the relationship between ADC and volumetric response after UAE. Receiver operating characteristic curve analysis was performed to determine the sensitivity and specificity of ADC for prediction of the potential response to UAE. Interclass correlation coefficient analysis was used to assess interobserver variability between two radiologists.ResultsVolume reduction rates of leiomyomas after UAE ranged from 0.2%–89.1% (mean, 44.1%). ADC ranged from 0.559 × 10^?3 mm²/s to 1.814 × 10^?3 mm²/s (mean, 1.170 × 10^?3 mm²/s). ADC was statistically significantly related to volumetric response of leiomyomas (P = .014). Using a threshold of 1.092 × 10^?3 mm²/s, the sensitivity and specificity of ADC for prediction of > 50% volume reduction of the leiomyoma after UAE were 82.6% and 52.3%, respectively. Using a threshold of 1.023 × 10^?3 mm²/s, the sensitivity and specificity of ADC for prediction of < 30% volume reduction were 80.8% and 33.3%, respectively. The interclass correlation coefficient for measuring ADC of uterine leiomyomas between two radiologists was 0.98.ConclusionsADC of uterine leiomyomas was significantly related to the volume reduction after UAE. ADC may be useful in predicting the potential response to UAE. A high ADC of the uterine leiomyoma may be associated with a greater volume reduction after UAE.     

High-Frequency Jet Ventilation under General Anesthesia Facilitates CT-Guided Lung Tumor Thermal Ablation Compared with Normal Respiration under Conscious Analgesic Sedation

PurposeTo determine whether technical difficulty of computed tomography (CT)–guided percutaneous lung tumor thermal ablations is altered with the use of high-frequency jet ventilation (HFJV) under general anesthesia (GA) compared with procedures performed with normal respiration (NR) under conscious sedation (CS).Materials and MethodsThermal ablation treatment sessions performed with NR under CS or HFJV under GA with available anesthesia records and CT fluoroscopic images were retrospectively reviewed; 13 and 33 treatment sessions, respectively, were identified. One anesthesiologist determined the choice of anesthesiologic technique independently. Surrogate measures of procedure technical difficulty—time duration, number of CT fluoroscopic acquisitions, and radiation dose required for applicator placement for each tumor—were compared between anesthesiologic techniques. The anesthesiologist time and complications were also compared. Parametric and nonparametric data were compared by Student independent-samples t test and χ² test, respectively.ResultsPatients treated with HFJV under GA had higher American Society of Anesthesiologists classifications (mean, 2.66 vs 2.23; P = .009) and smaller lung tumors (16.09 mm vs 27.38 mm; P = .001). The time duration (220.30 s vs 393.94 s; P = .008), number of CT fluoroscopic acquisitions (10.31 vs 19.13; P = .023), and radiation dose (60.22 mGy·cm vs 127.68 mGy·cm; P = .012) required for applicator placement were significantly lower in treatment sessions performed with HFJV under GA. There was no significant differences in anesthesiologist time (P = .20), rate of pneumothorax (P = .62), or number of pneumothoraces requiring active treatment (P = .19).ConclusionsHFJV under GA appears to reduce technical difficulty of CT-guided percutaneous applicator placement for lung tumor thermal ablations, with similar complication rates compared with treatment sessions performed with NR under CS. The technique is safe and may facilitate treatment of technically challenging tumors.     

Transcatheter CT Arterial Portography and CT Hepatic Arteriography for Liver Tumor Visualization during Percutaneous Ablation

PurposeTo evaluate the feasibility of combining transcatheter computed tomography (CT) arterial portography or transcatheter CT hepatic arteriography with percutaneous liver ablation for optimized and repeated tumor exposure.Materials and MethodsStudy participants were 20 patients (13 men and 7 women; mean age, 59.4 y; range, 40–76 y) with unresectable liver-only malignancies—14 with colorectal liver metastases (29 lesions), 5 with hepatocellular carcinoma (7 lesions), and 1 with intrahepatic cholangiocarcinoma (2 lesions)—that were obscure on nonenhanced CT. A catheter was placed within the superior mesenteric artery (CT arterial portography) or in the hepatic artery (CT hepatic arteriography). CT arterial portography or CT hepatic arteriography was repeatedly performed after injecting 30–60 mL 1:2 diluted contrast material to plan, guide, and evaluate ablation. The operator confidence levels and the liver-to-lesion attenuation differences were assessed as well as needle-to-target mismatch distance, technical success, and technique effectiveness after 3 months.ResultsTechnical success rate was 100%; there were no major complications. Compared with conventional unenhanced CT, operator confidence increased significantly for CT arterial portography or CT hepatic arteriography cases (P < .001). The liver-to-lesion attenuation differences between unenhanced CT, contrast-enhanced CT, and CT arterial portography or CT hepatic arteriography were statistically significant (mean attenuation difference, 5 HU vs 28 HU vs 70 HU; P < .001). Mean needle-to-target mismatch distance was 2.4 mm ± 1.2 (range, 0–12.0 mm). Primary technique effectiveness at 3 months was 87% (33 of 38 lesions).ConclusionsIn patients with technically unresectable liver-only malignancies, single-session CT arterial portography–guided or CT hepatic arteriography–guided percutaneous tumor ablation enables repeated contrast-enhanced imaging and real-time contrast-enhanced CT fluoroscopy and improves lesion conspicuity.